Today: 13 June 2026
Micron stock price slips as AI-memory trade faces test ahead of earnings
12 March 2026
1 min read

Micron stock price slips as AI-memory trade faces test ahead of earnings

New York—March 12, 2026, 2:44 PM EDT.

Micron Technology dropped $11.69 to $407 in Thursday afternoon trading, after touching an intraday peak at $418.50. Shares had slipped to $396.83 earlier in the session.

Applied Materials on Tuesday announced it’s teaming up with Micron and SK Hynix at its EPIC research center, aiming to push forward on new memory chip technology designed for AI and high-performance computing. The collaboration comes as Micron, Samsung Electronics and SK Hynix—still the world’s top memory-chip producers—scramble to meet soaring AI-driven demand. Reuters has estimated Big Tech will pour at least $630 billion into AI infrastructure this year.

Pricing is where things are biting hardest. TrendForce last month sharply boosted its outlook for conventional dynamic random access memory, or DRAM—now predicting prices to surge 90% to 95% in the first quarter. Previously, the group’s forecast sat at 55% to 60%. The shift comes as AI and data-center appetite continues to outpace available supply, widening the imbalance.

Micron announced back on Feb. 24 that it’s set to release its fiscal second-quarter results on March 18, with the earnings call slated for 2:30 p.m. Mountain time.

Micron’s latest quarterly results showed revenue hit $13.64 billion, with adjusted EPS coming in at $4.78 for its fiscal first quarter 2026. Looking ahead, the company is guiding for second-quarter revenue of $18.70 billion, give or take $400 million, and adjusted earnings per share of $8.42, either side of 20 cents.

Micron’s latest move with Applied offers a fresh narrative. Both firms said the collaboration targets high-bandwidth memory, or HBM—the speedy, low-power chips crucial for demanding AI tasks. CEO Sanjay Mehrotra called memory and storage “essential enablers of AI.” Technology chief Scott DeBoer added, the goal is to push ideas “into production faster.” markets.businessinsider.com

Atif Malik at Citi bumped his price target up to $430, pointing to “higher memory costs” as a key force behind increased spending from major cloud providers. Over at Susquehanna, Mehdi Hosseini set his target even higher at $525, noting that supply and demand may find equilibrium by mid-2027, once new clean-room facilities are operational. TradingView

Still, there’s a risk in play. Barron’s reported this week that Samsung Electronics and SK Hynix landed the first HBM4 supply slots on Nvidia’s Rubin platform. Analysts quoted by Barron’s noted Micron might get in later this year, and with 2026 capacity already spoken for, the company could dodge a revenue shortfall. Even so, the situation keeps the spotlight on how quickly Micron can grab share in the upcoming generation.

Stock Market Today

  • CSL Shares Rise 9.8% After FY26 Guidance Cut on Impairments and Channel Shifts
    June 13, 2026, 5:50 AM EDT. CSL (ASX:CSL) shares climbed 9.8% following a downward revision of its FY26 revenue and profit forecasts. The revision reflects impairments and writedowns linked to changes in U.S. immunoglobulin sales channels and weakening albumin prices in China. Despite these challenges, investor sentiment shows cautious optimism about CSL's operational turnaround prospects. The market now awaits CSL's full-year results and dividend update on 18 August 2026, which will offer clarity on revenue trends and any further impairments. CSL projects FY29 revenue of US$16.9 billion and earnings of US$3.3 billion, suggesting a potential 31% upside to current share prices. However, risks remain around sustained margin pressure and additional write-downs in plasma and albumin segments.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 13.06.2026

13 June 2026
LIVEMarkets rolling coverageStarted: June 13, 2026, 4:00 AM EDTUpdated: June 13, 2026, 6:08 AM EDT CSL Shares Rise 9.8% After FY26 Guidance Cut on Impairments and Channel Shifts June 13, 2026, 5:50 AM EDT. CSL (ASX:CSL) shares climbed 9.8% following a downward revision of its FY26 revenue and profit forecasts. The revision reflects impairments and writedowns linked to changes in U.S. immunoglobulin sales channels and weakening albumin prices in China. Despite these challenges, investor sentiment shows cautious optimism about CSL’s operational turnaround prospects. The market now awaits CSL’s full-year results and dividend update on 18 August 2026, which will offer
SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

13 June 2026
SGH closed at A$41.51, up 0.70% but underperformed the S&P/ASX 200’s 1.98% surge, as investors weighed solid cash flow and Boral margin gains against a high 36.03 P/E, mixed demand, and M&A risk; the next key catalyst is FY26 results on August 11, with analysts’ average target at A$47.64, 14.76% above Friday’s close.
Nu Holdings Ltd taps ex-TikTok executive Kim Farrell as Nubank steps up U.S., global push
Previous Story

Nu Holdings Ltd taps ex-TikTok executive Kim Farrell as Nubank steps up U.S., global push

Rivian Stock Price Falls Again After R2 SUV Reveal Raises Pressure on 2026 Growth
Next Story

Rivian Stock Price Falls Again After R2 SUV Reveal Raises Pressure on 2026 Growth

Go toTop